The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey model
- 1 April 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 148 (3) , 445-448
- https://doi.org/10.1016/0014-2999(88)90125-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmosetEuropean Journal of Pharmacology, 1986
- Sub-chronic administration of (?)-3-PPP and central dopamine receptor sensitivity changesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Therapeutic efficacy of a partial dopamine agonist in drug-free parkinsonian patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Transdihydrolisuride, a partial dopamine receptor antagonist: Effects on monoamine metabolismEuropean Journal of Pharmacology, 1984
- Dopamine receptor agonists: Intrinsic activity vs. state of receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisurideLife Sciences, 1983